当前位置: X-MOL 学术Curr. Opin. Oncol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Current treatment options for nodular lymphocyte-predominant Hodgkin lymphoma.
Current Opinion in Oncology ( IF 2.8 ) Pub Date : 2021-07-01 , DOI: 10.1097/cco.0000000000000774
Dennis A Eichenauer 1, 2 , Andreas Engert 1, 2
Affiliation  

Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare B cell-derived malignancy. This review aims at providing an overview of recent developments in the management of NLPHL.

中文翻译:

目前结节性淋巴细胞为主的霍奇金淋巴瘤的治疗选择。

结节性淋巴细胞为主的霍奇金淋巴瘤 (NLPHL) 是一种罕见的 B 细胞源性恶性肿瘤。本综述旨在概述 NLPHL 管理的最新发展。
更新日期:2021-07-07
down
wechat
bug